Dr. Frederick Ch'en
Office Managing PartnerTokyoBiography
For almost 20 years, Dr. Frederick Ch'en has combined
his scientific training and cultural background to advise
on a broad range of contentious and non-contentious
IP matters, especially in the life sciences area. Hisparticular focus is multijurisdictional patent litigation,
which also allows him to assist more pragmatically on
IP licensing and IP aspects of transactions (e.g., M&A,
private equity, and corporate finance).

Phone

A former research scientist at Oxford University (withthe top First Class Honours degree in Molecular andCellular Biochemistry (Balliol College) and a doctorate
in Medical Sciences (Merton College)), Frederick brings
technical insight into clients' disputes or transactions
coupled with cross-border perspectives that stem fromhaving been raised in four different cultures.

Languages

Frederick is a solicitor (England & Wales), U.S. attorney(California), U.S. patent attorney, a registered foreign
attorney in Japan, and a U.K. chartered biologist. He has
been recognised as a leading practitioner by variouspublications, including Chambers Asia, Legal 500, andMIP. Chambers Asia calls him "an exceptional IPspecialist" and "meticulous, responsive, andcomfortable working on complex matters in multiple
jurisdictions," and Legal 500 Asia Pacific an "excellent
advisor," "responsive and experienced," "diligent andtalented," and someone who "can easily understand thetechnical issues and is very good at figuring out asolution."

Commercial
Intellectual Property
Patents
Pharmaceuticals and Biotechnology
Regulatory
Trade Secrets and Confidential
Know-how
Digital Assets and Blockchain
IP Litigation, Arbitration, andAlternative Dispute Resolution

Prior to joining Hogan Lovells, Frederick was head of IP+81 3 5157 8263

Fax+81 3 5157 8210

Emailfrederick.chen@hoganlovells.com

EnglishJapanesePractices

in the Tokyo office of another top-tier law firm (20102013), having initially trained and worked for sevenyears in the London office of a top-tier "Magic Circle"
international law firm. He is a member of AIPPI Japan,
the Licensing Executive Society in Japan, and Pharma
Delegates. Frederick speaks English and Japanese.

Representative experience
Acting for various Japanese and non-Japanesecompanies with commercial disputes, most recently
arbitration matters (ICC and LCIA) in the Life Sciencesand Energy sectors, as well as civil litigation in
conjunction with Japanese bengoshi.
Acting for various global originator pharmaceuticalcompanies in relation to numerous patent disputes inJapan, including patent invalidation actions before theJapan Patent Office, appeals before the IP High Court
and patent infringement proceedings (as claimant anddefendant) before the Tokyo District Court inconjunction with Japanese bengoshi lawyers.
Acting for a Japanese pharmaceutical company inrelation to its European strategy for filing
Supplementary Protection Certificates in 26 countries.
Acting for a Japanese pharmaceutical company inrelation to regulatory data exclusivity in Europe and theU.S.
Acting for a Japanese pharmaceutical company inrelation to patent infringement proceedings against
three generic companies in Hong Kong.
Acting for a Japanese life sciences company in relation
to contract negotiations with a U.S. counterparty.

Industries
Life Sciences and Health Care

Areas of focus
Cell, Tissue, and Gene Therapies
Licensing and Commercial
Transactions
IP Rights in Transactions
Pharmaceuticals and Biotechnology
Regulatory Exclusivities, HatchWaxman, and Similar Statutes
Strategic Counseling and PortfolioDevelopment
Technology Contracts

Education and admissions
EducationPg.D.I.P.L.P. (Intellectual Property
Law & Practice), University of Bristol
Pg.D.L.P., Oxford Institute of LegalPractice
D.Phil., University of Oxford, Merton
CollegePg.D.L., Oxford Brookes University
M.Biochem. (Molecular and Cellular
Biochemistry), University of Oxford,
Balliol College, First Class Honours

Acting for a Japanese life sciences company in relation
to a patent licence from a U.S. counterparty.
Acting for a Japanese engineering company in relation
to its licensing negotiations with a European university
in respect of joint research, development andexploitation.
Acting for a Japanese electronics company in relation toUK patent litigation proceedings.

Memberships
Member and Editorial Board
Member, AIPPI (Japan)
Member, Licensing Executive Society(Japan)Member, Pharma Delegates (Japan)

Acting for a Japanese technology company in relation
to its global trademark and brand licensing.
Acting for a European pharmaceutical company inrelation to the assignment and licence-back of certain
patents from a Japanese pharmaceutical company inthe context of its multi-million US dollar acquisition bya U.S. pharmaceutical company.
Acting for Merck & Co., Inc. in relation to defending
patent revocation proceedings in relation to its enzyme
inhibitor product (finasteride), a ground-breaking casethat changed the English law on the patentability of
dosing regimens and the rules of precedent in the UK
Court of Appeal.

Member and Chartered Biologist,
Royal Society of Biology (UK)
Member, Biochemical Society (UK)Bar admissions andqualifications
Solicitor, England and Wales
California
U.S. Patent and Trademark Office
Japan - Daiichi Tokyo Bar
Association (Gaikokuho JimuBengoshi)Awards and rankings
Band 1 for Japan Intellectual Property: International(10 years ranked), Chambers Asia-Pacific, 2024
Band 1 for Life Sciences in Japan (7 years ranked),Chambers Asia-Pacific, 2024
Band 1 for Japan Intellectual Property: International(9 years ranked), Chambers Global, 2024
Leading Individual for Intellectual Property in Japan(6 years ranked), The Legal 500 Asia-Pacific, 2024
Leading individual for Patent Litigation and Patent
Transactions in Japan, IAM Patent 1000, 2017-2024
Patent Star in Japan, Managing Intellectual Property
IP Stars, 2014-2024
Sole winner of Client Choice Award for Life Sciencesin Japan, Lexology, 2022
Sole winner of Client Choice Award for Patents inJapan, International Law Office (now Lexology), 2017,2018, 2021
Named as one of Asia’s Top 15 IP Lawyers, AsianLegal Business, 2021
Foreign Lawyer of the Year, Asian Legal BusinessJapan Law Awards, 2020
Global Elite Thought Leader for Life Science - Patent
Litigation, Who's Who Legal, 2023
Recommended for Life Science - Patent Litigation,

Court admissions
Senior Courts of England and Wales

Accolades...armed with a background in
medical sciences, Ch’en tackles his
instructions in a 'responsive andtimely' manner, 'cooperating
seamlessly with both local andforeign peers.'

IAM Patent 1000, 2018...extremely hardworking, friendlyand brilliant.

Legal 500 Asia-Pacific 2019
Frederick Ch'en attracts widespreadacknowledgement for his
outstanding blend of 'strong
knowledge about scientific areas'
with his patent expertise. Dr Ch'en
has impeccable scienceWho's Who Legal, 2023
Recommended for Life Science - Regulatory, Who's
Who Legal, 2023

Latest thinking and events
Hogan Lovells Events
Tokyo: Life Sciences and Health Care Horizons
2024
Press releases
Hogan Lovells advises Nissan on the restructuringof its joint India operations with Renault
Hogan Lovells Events
Hogan Lovells APAC Life Sciences and Health CareWebinar Series - Spotlight on the U.S. - Session 4
Hogan Lovells Events
Select IP with Hogan Lovells | Webinar no. 25:
Recent comparative patent issues and trends inconnection with: (1) antibody patenting and (2) AI
Analysis of IP landscape (Greater China focus):
update on patents and patent licensing, and current
trends in trademarks, including insights from INTA
Conference 2024
Hogan Lovells Events
Hogan Lovells APAC Life Sciences and Health Care
Webinar Series - Spotlight on the U.S. - Session 3

qualifications including a doctorate
in medical sciences which he brings
to bear when advising clients onareas of contentious and noncontentious IP, and regulatoryregimes.

Chambers Asia-Pacific 2018
Frederick Ch'en combines anexpertise in patents with animpressive knowledge base in the
medical sciences. For clients, 'hisstrengths and qualities are great
diligence, rich knowledge in boththe IP and science areas of thepharmaceutical field...'Chambers Asia-Pacific 2016
Frederick Ch'en is admired for his
depth of knowledge in the life
sciences sector. Sources remark: 'He
is a very talented lawyer with a very
good background inpharmaceuticals and bioscience.'

Chambers Asia-Pacific 2017
Fred is very courteous,conscientious and knowledgeable
about the law, the relevant science,and the relevant business areas.

Legal 500 Asia-Pacific 2022
He is quick to understand relevant
legal issues and has the ability to
distill complex legal issues intoeasy-to-understand ones. His

communication skills are superb
and he is also appropriately creativein his legal approaches.

Chambers Asia-Pacific 2020
'He’s never afraid to tell you if hethinks you’re wrong' and combinedwith his 'practical and prompt
advice, and his experience inoverseeing international arbitration,
represents exceptional value formoney'.

IAM Patent 1000, 2018
Newly featured life sciences sage
Frederick Ch’en is the 'mostpractical of lawyers with a great
business mind. He understands
clients’ needs very quickly andalways gives prompt, valuable andclear advice on Japanese law andcustoms'.

IAM Patent 1000 2017